Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Snape

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Wellcome Open Research|November 2, 2019
UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidenceHolly B Bratcher, Charlene M C Rodrigues, Adam Finn, et al.
The Lancet. Microbe|April 20, 2023
Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trialAnna Calvert, Gayatri Amirthalingam, Nick Andrews, et al.
Infection|June 14, 2024
Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemicIvo Zeller, Andreas Weiss, Stefanie Arnolds, et al.
NPJ Vaccines|July 13, 2023
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in childrenDmitri Kazmin, Elizabeth A Clutterbuck, Giorgio Napolitani, et al.
The Journal of Clinical Investigation|October 17, 2022
Elevations in blood glucose before and after the appearance of islet autoantibodies in childrenKatharina Warncke, Andreas Weiss, Peter Achenbach, et al.
Molecular Systems Biology|November 19, 2020
Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccineDaniel O'Connor, Marta Valente Pinto, Dylan Sheerin, et al.
The Lancet. Infectious Diseases|November 20, 2020
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trialAndrew J Pollard, Odile Launay, Jean-Daniel Lelievre, et al.
Lancet (London, England)|November 14, 2025
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trialAnette-Gabriele Ziegler, Peter Achenbach, Andreas Weiß, et al.
Archives of Disease in Childhood|July 8, 2024
An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infantsAnna Calvert, Nick Andrews, Sheula Barlow, et al.
The Journal of Infectious Diseases|April 1, 2020
Low Sensitivity of BinaxNOW RSV in InfantsRoy P Zuurbier, Louis J Bont, Annefleur C Langedijk, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Wellcome Open Research|November 2, 2019
UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidenceHolly B Bratcher, Charlene M C Rodrigues, Adam Finn, et al.
The Lancet. Microbe|April 20, 2023
Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trialAnna Calvert, Gayatri Amirthalingam, Nick Andrews, et al.
Infection|June 14, 2024
Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemicIvo Zeller, Andreas Weiss, Stefanie Arnolds, et al.
NPJ Vaccines|July 13, 2023
Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in childrenDmitri Kazmin, Elizabeth A Clutterbuck, Giorgio Napolitani, et al.
The Journal of Clinical Investigation|October 17, 2022
Elevations in blood glucose before and after the appearance of islet autoantibodies in childrenKatharina Warncke, Andreas Weiss, Peter Achenbach, et al.
Molecular Systems Biology|November 19, 2020
Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccineDaniel O'Connor, Marta Valente Pinto, Dylan Sheerin, et al.
The Lancet. Infectious Diseases|November 20, 2020
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trialAndrew J Pollard, Odile Launay, Jean-Daniel Lelievre, et al.
Lancet (London, England)|November 14, 2025
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trialAnette-Gabriele Ziegler, Peter Achenbach, Andreas Weiß, et al.
Archives of Disease in Childhood|July 8, 2024
An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infantsAnna Calvert, Nick Andrews, Sheula Barlow, et al.
The Journal of Infectious Diseases|April 1, 2020
Low Sensitivity of BinaxNOW RSV in InfantsRoy P Zuurbier, Louis J Bont, Annefleur C Langedijk, et al.
Pageof 17